VirTra Q3 revenue misses estimates, hurt by federal funding delays

Reuters
Nov 11
VirTra Q3 revenue misses estimates, hurt by federal funding delays

Overview

  • Firearms training simulator provider VirTra Q3 revenue fell 29% yr/yr, missing analyst expectations due to funding delays

  • Adjusted EBITDA for Q3 dropped 91% yr/yr, reflecting challenging funding environment

  • Company secured $4.8 mln contract in Colombia, expanding international presence

Outlook

  • Company sees increased backlog and pipeline tied to grant-driven purchasing

  • VirTra expects to benefit from DOJ COPS grant program funding

Result Drivers

  • FUNDING DELAYS - Slower federal funding cycle affected revenue recognition, impacting Q3 results

  • INTERNATIONAL EXPANSION - Secured $4.8 mln contract in Colombia and expanded presence in Canada

  • NEW PRODUCT LAUNCH - Introduced V-One Portable Simulator for smaller agencies

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$5.30 mln

$6.99 mln (2 Analysts)

Q3 EPS

-$0.03

Q3 Net Income

-$400,000

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the aerospace & defense peer group is "buy"

  • Wall Street's median 12-month price target for VirTra Inc is $8.25, about 34.7% above its November 7 closing price of $5.39

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 25 three months ago

Press Release: ID:nGNX95z88S

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10